You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API olanzapine and samidorphan l-malate

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing olanzapine and samidorphan l-malate

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Alkermes Inc	LYBALVI	olanzapine and samidorphan l-malate	65757-651	CELLULOSE, MICROCRYSTALLINE	2031-08-30
Alkermes Inc	LYBALVI	olanzapine and samidorphan l-malate	65757-651	CROSPOVIDONE	2031-08-30
Alkermes Inc	LYBALVI	olanzapine and samidorphan l-malate	65757-651	FERRIC OXIDE YELLOW	2031-08-30
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for olanzapine and samidorphan l-malate

Excipient focus: CELLULOSE, MICROCRYSTALLINE

olanzapine and samidorphan l-malate drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alkermes Inc	olanzapine and samidorphan l-malate	65757-651
>Company	>Ingredient	>NDC

olanzapine and samidorphan l-malate drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSPOVIDONE

olanzapine and samidorphan l-malate drug variants containing CROSPOVIDONE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alkermes Inc	olanzapine and samidorphan l-malate	65757-651
>Company	>Ingredient	>NDC

olanzapine and samidorphan l-malate drug variants not containing CROSPOVIDONE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE YELLOW

olanzapine and samidorphan l-malate drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alkermes Inc	olanzapine and samidorphan l-malate	65757-651
>Company	>Ingredient	>NDC

olanzapine and samidorphan l-malate drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

olanzapine and samidorphan l-malate drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alkermes Inc	olanzapine and samidorphan l-malate	65757-651
>Company	>Ingredient	>NDC

olanzapine and samidorphan l-malate drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

olanzapine and samidorphan l-malate drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alkermes Inc	olanzapine and samidorphan l-malate	65757-651
>Company	>Ingredient	>NDC

olanzapine and samidorphan l-malate drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

olanzapine and samidorphan l-malate drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alkermes Inc	olanzapine and samidorphan l-malate	65757-651
>Company	>Ingredient	>NDC

olanzapine and samidorphan l-malate drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

olanzapine and samidorphan l-malate drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alkermes Inc	olanzapine and samidorphan l-malate	65757-651
>Company	>Ingredient	>NDC

olanzapine and samidorphan l-malate drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

olanzapine and samidorphan l-malate drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alkermes Inc	olanzapine and samidorphan l-malate	65757-651
>Company	>Ingredient	>NDC

olanzapine and samidorphan l-malate drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TRIACETIN

olanzapine and samidorphan l-malate drug variants containing TRIACETIN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alkermes Inc	olanzapine and samidorphan l-malate	65757-651
>Company	>Ingredient	>NDC

olanzapine and samidorphan l-malate drug variants not containing TRIACETIN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.